Skip to main content
logo
Olema Pharmaceuticals, Inc. (OLMA)
NASDAQ: OLMA · Real-Time Price · USD
8.23
-0.04 (-0.54%)
At close: Oct 2, 2026, 4:00 PM EDT
8.34
+0.12 (1.40%)
Pre-market: Oct 5, 2026, 4:25 AM EDT

Olema Pharmaceuticals Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
-204.57-162.45-129.47-96.66-104.79-71.1
Depreciation & Amortization
0.450.490.390.380.360.16
Loss (Gain) From Sale of Assets
--0.010.11--
Loss (Gain) From Sale of Investments
-----0.28
Stock-Based Compensation
31.5717.5922.5817.2618.8315.91
Other Operating Activities
-3.77-5.12-7.03-4.230.511.22
Change in Accounts Payable
0.584.62.512.320.35-0.68
Change in Other Net Operating Assets
11-1.826.65-2.912.673.51
Operating Cash Flow
-164.74-146.72-104.35-83.73-82.07-50.69
Operating Cash Flow Growth
------

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
-0.22--0.16--0.36-1.58
Sale of Property, Plant & Equipment
---0.01--
Investment in Securities
-99.32-155.76-93.37-4.8791.84-273.86
Investing Cash Flow
-99.54-155.76-93.53-4.8591.48-275.44

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Long-Term Debt Issued
-3----
Net Debt Issued (Repaid)
-3----
Issuance of Common Stock
273.54227.92275.48133.420.481.39
Other Financing Activities
-13.14-19.62-6.66---
Financing Cash Flow
260.4211.3268.82133.420.481.39

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Cash Flow
-3.87-91.1870.9444.849.89-324.74

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
-164.96-146.72-104.51-83.73-82.43-52.27
Free Cash Flow Growth
------
Free Cash Flow Per Share
-1.72-1.69-1.78-1.85-2.06-1.32
Levered Free Cash Flow
-89.06-82.9-42.7-43.1-41.64-26.52
Unlevered Free Cash Flow
-89.06-82.9-42.7-43.1-41.64-26.52

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Change in Working Capital
11.582.789.16-0.593.022.83
SEC Filings: 10-K · 10-Q